Literature DB >> 3173598

Prevention of recurrent urinary tract infections in postmenopausal women.

M Privette1, R Cade, J Peterson, D Mars.   

Abstract

Twelve postmenopausal women who experienced frequent urinary tract infections were found to have atrophic vaginitis. Four of them who were taking sulfonamide preparations chronically also had an interstitial nephritis manifest by decreasing glomerular filtration rate and eosinophiluria. Treatment consisted of a Betadine douche daily for 1 week, administration of an appropriate nonsulfonamide antibiotic, and institution of estrogen therapy to restore glycogen deposition in the vaginal epithelium and promote return of a normal vaginal pH and bacterial flora. Prior to estrogen therapy, the frequency of infection was four per patient per year. During a follow-up observation period ranging from 2 to 8 years, there have been only four infections in the entire group. When sulfonamides were discontinued in the 4 patients with manifestations of interstitial nephritis, the eosinophiluria cleared, and the glomerular filtration rate increased significantly.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3173598     DOI: 10.1159/000185111

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

Review 1.  Management of lower urinary tract infections.

Authors:  R R Bailey
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 2.  Antibiotics for preventing recurrent urinary tract infection in non-pregnant women.

Authors:  X Albert; I Huertas; I I Pereiró; J Sanfélix; V Gosalbes; C Perrota
Journal:  Cochrane Database Syst Rev       Date:  2004

3.  Recurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a Markov chain Monte Carlo model.

Authors:  Samantha J Eells; Kiran Bharadwa; James A McKinnell; Loren G Miller
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079

Review 4.  Waging war against uropathogenic Escherichia coli: winning back the urinary tract.

Authors:  Kelsey E Sivick; Harry L T Mobley
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.